Cited 0 time in
The effects of a new human leukocyte elastase inhibitor (recombinant guamerin) on cerulein-induced pancreatitis in rats
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jo, Yun Ju | - |
| dc.contributor.author | Choi, Ho Soon | - |
| dc.contributor.author | Jun, Dae Won | - |
| dc.contributor.author | Lee, Oh Young | - |
| dc.contributor.author | Kang, Joo Seop | - |
| dc.contributor.author | Park, Il Gyu | - |
| dc.contributor.author | Jung, Kyung Hwan | - |
| dc.contributor.author | Hahm, Joon Soo | - |
| dc.date.accessioned | 2022-12-21T02:09:39Z | - |
| dc.date.available | 2022-12-21T02:09:39Z | - |
| dc.date.issued | 2008-07 | - |
| dc.identifier.issn | 1567-5769 | - |
| dc.identifier.issn | 1878-1705 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/178215 | - |
| dc.description.abstract | Background: Pancreatic and neutrophil elastase can aggravate or induce acute pancreatitis. Although increased elastase levels in the plasma of pancreatitis patients and animal models have been reported, the mechanism by which elastase is involved in the pathogenesis of acute pancreatitis has not yet been elucidated. We aimed to investigate the effects and the possible mechanism of a new human leukocyte elastase inhibitor (recombinant guamerin) in the treatment of cerulein-induced acute pancreatitis in rats. Methods: Fifty Sprague-Dawley rats were divided into three groups: a saline-infused control group (I), a cerulein-induced acute pancreatitis group (II), and a cerulein plus guamerin infusion group (III). Guamerin (1-2 mu mol/kg/h) was infused continuously in group III. The severity of pancreatitis was determined biochemically, histologically, and by cytokine changes between groups I, II and III. Results: Significant differences in serum amylase, lipase, and pancreatic wet weight were observed in each group, respectively (group 1; 2346.2 IU/L, 9.9 IU/L, 1.4 +/- 0.3 g, group II; 13,596.8 IU/L, 7439.4 IU/L, 2.2 +/- 0.5 g, group III; 9443.2 IU/L, 4516.3 IU/L, 1.7 +/- 0.6 g). Serum IL-6 and TNF-alpha [AU1]level peaked 1-4 h and 1-2 h. After the induction of pancreatitis, IL-6 and TNF-alpha levels were decreased in group III than group 11, (group 1; 13.1/ 4.0 pg/mL, group II; 198.5/63.2 pg/mL, group III; 102.1/13.1 pg/mL), but no significant difference in IL-1 beta was observed. Histologic gradings and severity, such as vacuolization, inflammation, lobular disarray, and edema of the pancreas, were significantly tower in the cerulein plus guamerin infusion group III. Conclusions: Recombinant guamerin, a new human leukocyte elastase inhibitor, may decrease the severity of pancreatitis and diminish pancreatic acinar cell injury by inhibition of neutrophilic infiltration and cytokine activation in the initial stage of cerulein-induced acute pancreatitis in rats. | - |
| dc.format.extent | 8 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | The effects of a new human leukocyte elastase inhibitor (recombinant guamerin) on cerulein-induced pancreatitis in rats | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.intimp.2008.02.014 | - |
| dc.identifier.scopusid | 2-s2.0-43649098096 | - |
| dc.identifier.wosid | 000256710500002 | - |
| dc.identifier.bibliographicCitation | International Immunopharmacology, v.8, no.7, pp 959 - 966 | - |
| dc.citation.title | International Immunopharmacology | - |
| dc.citation.volume | 8 | - |
| dc.citation.number | 7 | - |
| dc.citation.startPage | 959 | - |
| dc.citation.endPage | 966 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Immunology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Immunology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS | - |
| dc.subject.keywordPlus | PLATELET-ACTIVATING-FACTOR | - |
| dc.subject.keywordPlus | POST-ERCP PANCREATITIS | - |
| dc.subject.keywordPlus | GABEXATE MESYLATE | - |
| dc.subject.keywordPlus | PREVENTION | - |
| dc.subject.keywordPlus | MULTICENTER | - |
| dc.subject.keywordPlus | ULINASTATIN | - |
| dc.subject.keywordPlus | PROTEASES | - |
| dc.subject.keywordPlus | SEVERITY | - |
| dc.subject.keywordAuthor | leukocyte elastase inhibitor | - |
| dc.subject.keywordAuthor | guamerin | - |
| dc.subject.keywordAuthor | pancreatitis | - |
| dc.subject.keywordAuthor | interleukin-6 | - |
| dc.subject.keywordAuthor | tumor necrosis factor-alpha | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S156757690800074X?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
